Cargando…

Impaired innate antiviral defenses in COVID-19: Causes, consequences and therapeutic opportunities

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a recently emerged pathogen that has caused coronavirus disease 2019 (COVID-19), the worst pandemic of our times leading to tremendous loss of human life and unprecedented measures of social distancing. COVID-19 symptom manifestations r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Galani, Ioanna-Evdokia, Andreakos, Evangelos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576141/ https://www.ncbi.nlm.nih.gov/pubmed/34815163 http://dx.doi.org/10.1016/j.smim.2021.101522

Ejemplares similares

Lambda interferons come to light: dual function cytokines mediating antiviral immunity and damage control
por: Andreakos, Evangelos, et al.
Publicado: (2019)

Protocol for influenza A virus infection of mice and viral load determination
por: Galani, Ioanna-Evdokia, et al.
Publicado: (2022)

Lipids in Innate Antiviral Defense
por: Schoggins, John W., et al.
Publicado: (2013)

Interferon-λs: Front-Line Guardians of Immunity and Homeostasis in the Respiratory Tract
por: Andreakos, Evangelos, et al.
Publicado: (2017)

Antiviral Defense and Innate Immune Memory in the Oyster
por: Green, Timothy J., et al.
Publicado: (2018)

Innate antiviral defenses in body fluids and tissues
por: Baron, Samuel, et al.
Publicado: (2000)

Asthma exacerbations: a molecular dichotomy between antiviral and pro-inflammatory responses revealed
por: Andreakos, Evangelos
Publicado: (2012)

Bone metastases: Causes, consequences and therapeutic opportunities
por: Perez-Garcia, Jose, et al.
Publicado: (2013)

RNA interference: a multifaceted innate antiviral defense
por: Kumar, Ajit
Publicado: (2008)

Therapeutic opportunities of edible antiviral plants for COVID-19
por: Patel, Bhoomika, et al.
Publicado: (2021)

Editorial: Cellular Senescence: Causes, Consequences and Therapeutic Opportunities
por: Wong, Pooi-Fong
Publicado: (2022)

ISGylation in Innate Antiviral Immunity and Pathogen Defense Responses: A Review
por: Zhang, Mengdi, et al.
Publicado: (2021)

Severity of neonatal influenza infection is driven by type I interferon and oxidative stress
por: Kumova, Ogan K., et al.
Publicado: (2022)

Innate antiviral defense demonstrates high energetic efficiency in a bony fish
por: Polinski, Mark P., et al.
Publicado: (2021)

COVID‐19: lambda interferon against viral load and hyperinflammation
por: Andreakos, Evangelos, et al.
Publicado: (2020)

TRIMming Type I Interferon-Mediated Innate Immune Response in Antiviral and Antitumor Defense
por: Wang, Ling, et al.
Publicado: (2021)

Causes and Consequences of Innate Immune Dysfunction in Cirrhosis
por: Irvine, Katharine Margaret, et al.
Publicado: (2019)

Airway Surface Liquid and Impaired Antiviral Defense in Cystic Fibrosis
por: Voynow, Judith A., et al.
Publicado: (2020)

Author Correction: Innate antiviral defense demonstrates high energetic efficiency in a bony fish
por: Polinski, Mark P., et al.
Publicado: (2023)

Tumor angiogenesis: causes, consequences, challenges and opportunities
por: Lugano, Roberta, et al.
Publicado: (2019)

Corrigendum: Causes and Consequences of Innate Immune Dysfunction in Cirrhosis
por: Irvine, Katharine Margaret, et al.
Publicado: (2019)

Antiviral Defense in Invertebrates
por: Flenniken, Michelle L.
Publicado: (2018)

Oral antiviral treatments for COVID-19: opportunities and challenges
por: Rahmah, Laila, et al.
Publicado: (2022)

Mosquito antiviral defense mechanisms: a delicate balance between innate immunity and persistent viral infection
por: Lee, Wai-Suet, et al.
Publicado: (2019)

Innate immune signaling in trophoblast and decidua organoids defines differential antiviral defenses at the maternal-fetal interface
por: Yang, Liheng, et al.
Publicado: (2022)

Innate Humoral Defense Factors
por: Hajishengallis, George, et al.
Publicado: (2015)

Innate Humoral Defense Factors
por: Russell, Michael W., et al.
Publicado: (2005)

Antiviral defense: interferons and beyond
por: Stetson, Daniel B., et al.
Publicado: (2006)

Evolution of viruses and antiviral defense
por: Moelling, Karin
Publicado: (2009)

Dendritic Cells and Antiviral Defense
por: Mailliard, Robbie B.
Publicado: (2020)

Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapy
por: Cruz-Teran, Carlos, et al.
Publicado: (2021)

Correction: Oral antiviral treatments for COVID-19: opportunities and challenges
por: Rahmah, Laila, et al.
Publicado: (2022)

Innate immune signaling and immunothrombosis: New insights and therapeutic opportunities
por: Ryan, Tristram A. J., et al.
Publicado: (2022)

Human Cytomegalovirus Glycoprotein UL141 Targets the TRAIL Death Receptors to Thwart Host Innate Antiviral Defenses
por: Smith, Wendell, et al.
Publicado: (2013)

Antiviral Innate Immune Responses in Autoimmunity: Receptors, Pathways, and Therapeutic Targeting
por: Stergioti, Eirini Maria, et al.
Publicado: (2022)

Innate antiviral immunity is impaired in young patients with hand foot and mouth diseases
por: Yang, Y
Publicado: (2011)

Isocitrate dehydrogenase variants in cancer — Cellular consequences and therapeutic opportunities
por: Liu, Shuang, et al.
Publicado: (2020)

Structural Chromosome Instability: Types, Origins, Consequences, and Therapeutic Opportunities
por: Siri, Sebastián Omar, et al.
Publicado: (2021)

Depletion of Gut Microbiota Impairs Gut Barrier Function and Antiviral Immune Defense in the Liver
por: Guo, Weina, et al.
Publicado: (2021)

Innate Immune Pathways in Host Defense
por: Kanneganti, Thirumala-Devi, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_p5sh4ihrnngem07c455nk5colb